Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Its Not Recommended by Either the FDA or the Drug Maker Both the US Food and Drug Administration (FDA) and Novo Nordisk, the maker of Wegovy and Ozempic, have warned against splitting semaglutide doses exactly for the reasons weve outlined above: its not sterile, it introduces too much room for error, and it can increase the risk of side effects
Alternative Strategies and Medication Adjustments When dietary and lifestyle modifications prove insufficient, additional therapeutic options may help manage bloating whilst continuing GLP-1 therapy
Ultimately, an Endocrinologists assessment is essential to determine which medication is more suitable, based on medical history and individual treatment goals
Find your concentration: divide the vial size (mg) by the bacteriostatic water added (mL)
